Abstract
The literature describing the impact of cancer and its treatment on spermatogenesis, likelihood of natural conception, and discussion of potential congenital abnormalities as a result of DNA damage in sperm is discussed in this chapter.
Many patients diagnosed with cancer are of reproductive age. As advancements in medicine lead to improvements in cancer diagnosis and treatment, more of these younger patients survive. Given increasing 5-year survival rates, it is becoming increasingly important to consider future fertility in patients undergoing cancer treatment. Therefore all males of pubertal age and older should have a discussion with their physician regarding fertility preservation prior to receiving treatment for cancer.
Men with cancer before receiving treatment are more frequently observed to have abnormal semen parameters due to anatomic and physiologic disruptions. This has been observed for many different types of malignancies, but it is magnified in the testicular cancer population.
Among the different modalities for cancer treatment, chemotherapy and radiation have been shown to cause direct damage to spermatogonia and therefore affect spermatogenesis. Surgery affects fertility by alterations in anatomy. After treatment with chemotherapy, abnormal sperm DNA fragmentation and aneuploidy rates have been observed.
With regard to congenital abnormalities of offspring as a result of cancer treatment, data suggest that children born to fathers within the first 2 years of cancer diagnosis and those men diagnosed with cancer in childhood have a statistically significant, but likely clinically insignificant, increase in congenital abnormalities. When compared with natural conception, assisted reproductive technology was associated with increased risk for low birth weight and preterm delivery, and a 20% increased risk of major congenital abnormality regardless of paternal cancer history.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
Howlader N, et al. SEER cancer statistics review 1975–2009. Bethesda, MD: National Cancer Institute; 2012.
Loren A, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.
Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86(4):697–709.
Kohler TS, Kondapalli LA, Shah A, et al. Results from the survey of preservation of adolescent reproduction (SPARE) study: gender disparity in deliver of fertility preservation message in adolescents with cancer. J Assist Reprod Genet. 2011;28(3):269–77.
Salonia A, Capogrosso P, Castiglione F, et al. Sperm banking is of key importance in patients with prostate cancer. Fertil Steril. 2013;100:367–372.e1.
Setchell BP, Brooks DE. Anatomy, vasculature, innervation and fluids of the male reproductive tract. New York: Raven Press; 1988.
Muller J, Skakkebaek NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl. 1983;6:143–56.
Clermont Y. The cycle of the seminiferous epithelium in man. Am J Anat. 1963;112:35–51.
Clermont Y. Spermatogenesis in man. A study of the spermatogonial population. Fertil Steril. 1966;17:705–21.
Clermont Y. Renewal of spermatogonia in man. Am J Anat. 1966;118:509–24.
Clermont Y. Two classes of spermatogonial stem cells in the monkey (Cercopithecus aethiops). Am J Anat. 1969;126:57–71.
Simorangkir DR, Marshall GR, Ehmcke J, Schlatt S, Plant TM. Prepubertal expansion of dark and pale type A spermatogonia in the rhesus monkey (Macaca mulatta) results from proliferation during infantile and juvenile development in a relatively gonadotropin independent manner. Biol Reprod. 2005;73:1109–15.
van Alphen MM, van de Kant HJ, de Rooij DG. Repopulation of the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res. 1988;113:487–500.
Ehmcke J, Simorangkir DR, Schlatt S. Identification of the starting point for spermatogenesis and characterization of the testicular stem cell in adult male rhesus monkeys. Hum Reprod. 2005;20:1185–93.
Kanatsu-Shinohara M, Toyokuni S, Morimoto T, Matsui S, Honjo T, Shinohara T. Functional assessment of self-renewal activity of male germline stem cells following cytotoxic damage and serial transplantation. Biol Reprod. 2003;68:1801–7.
Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59:665–78.
Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120:161–5.
Ridola V, Fawaz O, Aubier F, et al. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer. 2009;45:814–8.
Williams DH, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pre-treatment semen parameters in men with cancer. J Urol. 2009;181:736–40.
Hendry WF, Stedronksa J, Jones CR, Blackmore CA, Barrett A, Peckham MJ. Semen analysis in testicular cancer and Hodgkin’s disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol. 1983;55:769–73.
Dada R, Gupta NP, Kucheria K. Spermatogenic arrest in men with testicular hyperthermia. Teratog Carcinog Mutagen. 2003;(suppl 1):235–43.
van der Kaaij MA, Heutte N, van Echten-Arends J, et al. Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 2009;94:1691–7.
Barr RD, Clark DA, Booth JD. Dyspermia in men with localised Hodgkin’s disease. A potentially reversible immune-mediated disorder. Med Hypotheses. 1993;40:165–8.
Ståhl O, Eberhard J, Cavallin-Ståhl E, Jepson K, Friberg B, Tingsmark C, Spanò M, Giwercman A. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl. 2008;32(6):695–703.
Spermon JR, Ramos L, Wetzels AMM, Sweep CGJ, Braat DDM, Kiemeney LALM, Witjes JA. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod. 2006;21(7):1781–6.
Tournaye H, Dohle GR, Barratt CL. Fertility preservation in men with cancer. Lancet. 2014;384:1295–301.
Hsiao W, Stahl PJ, Osterberg EC, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol. 2011;29:1607–11.
Kort JD, Eisenberg ML, Millheiser LS, Westphal LM. Fertility issues in cancer survivorship. CA Cancer J Clin. 2014;64:118–34.
van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer. 2009;52:108–12.
Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer. 1992;70:2703–12.
Marmor D, Duyck F. Male reproductive potential after MOPP therapy for Hodgkin’s disease: a long-term survey. Andrologia. 1995;27:99–106.
Tal R, Botchan A, Hauser R, Yogev L, Paz G, Yavetz H. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 2000;15:1985–8.
Behringer K, Mueller H, Goergen H, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31:231–9.
Romerius P, Ståhl O, Moëll C, et al. High risk of azoospermia in men treated for childhood cancer. Int J Androl. 2011;34:69–76.
Anserini P, Chiodi S, Spinelli S, et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002;30:447–51.
Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.
Trottmann M, Becker AJ, Stadler T, et al. Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol. 2007;52:355–67.
Petersen PM, Giwercman A, Daugaard G, Rørth M, Petersen JH, Skakkeaek NE, Hansen SW, von der Maase H. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol. 2002;20(6):1537–43.
Thomas C, Cans C, Pelletier R, De Robertis C, Hazzouri M, Sele B, Rousseaux S, Hennebicq S. No long-term increase in sperm aneuploidy rates after anticancer therapy: sperm fluorescence in situ hybridization analysis in 26 patients treated for testicular cancer or lymphoma. Clin Cancer Res. 2004;10(19):6535–43.
Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin’s lymphoma patients. Hum Reprod. 2008;23(2):251–8.
O’Donovan M. An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy. Andrologia. 2005;37:83–90.
Marchetti F, Wyrobek AJ. Mechanisms and consequences of paternally-transmitted chromosomal abnormalities. Birth Defects Res C Embryo Today. 2005;75(2):112–29.
Ståhl O, Boyd HA, Giwercman A, Lindholm M, Jensen A, Kjær SK, Anderson H, Cavallin-Ståhl E, Rylander L. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst. 2011;103(5):398–406.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
McDowell, Z.J., Hockenberry, M.S., Lipshultz, L.I. (2018). The Effect of Cancer and Its Treatment on Natural-Born Offspring. In: Majzoub, A., Agarwal, A. (eds) The Complete Guide to Male Fertility Preservation. Springer, Cham. https://doi.org/10.1007/978-3-319-42396-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-42396-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42395-1
Online ISBN: 978-3-319-42396-8
eBook Packages: MedicineMedicine (R0)